Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The FDA and Off-Label Promotion: First Amendment Considerations Addressed (and Rejected) in FDA Memorandum
The FDA and Off-Label Promotion: First Amendment Considerations Addressed (and Rejected) in FDA Memorandum
The FDA and Off-Label Promotion: First Amendment Considerations Addressed (and Rejected) in FDA Memorandum
Submitted by
admin
on January 24, 2017 - 10:17am
Source:
FDA Law Blog
News Tags:
FDA
off-label
First Amendment
free speech
Headline:
The FDA and Off-Label Promotion: First Amendment Considerations Addressed (and Rejected) in FDA Memorandum
Do Not Allow Advertisers to Use My Personal information
